Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Non-Current Assets (2021 - 2026)

Tevogen's (TVGN) quarterly Non-Current Assets came in at $2.8 million in Q1 2026, up 179.29% on a YoY basis from $995371.0 in Q1 2025, and down 2.22% quarter-over-quarter from $2.8 million in Q4 2025.

Analysis

Tevogen (TVGN) Non-Current Assets (2021 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Non-Current Assets for 6 consecutive years, with $2.8 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 179.29% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.2 million (up 174.18% YoY), and the FY2025 full-year result was $2.8 million, up 158.29% from the prior year.
  • Non-Current Assets declined to $2.8 million in Q1 2026 per TVGN's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $356.9 million in Q4 2022 and bottomed at $761755.0 in Q3 2024.
  • Historically, Non-Current Assets has averaged $88.9 million across 5 years, with a median of $2.8 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Non-Current Assets slumped 98.94% in 2023, then jumped 211.38% in 2025.
  • Over 5 years, Non-Current Assets stood at $356.9 million in 2022, then plunged by 98.94% to $3.8 million in 2023, then tumbled by 70.9% to $1.1 million in 2024, then jumped by 158.29% to $2.8 million in 2025, then declined by 2.22% to $2.8 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $2.8 million, $2.8 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 441.00 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 279.00 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 451.27 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 523.50 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 150.83 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 207.76 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 35.91 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 964.69 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 238.14 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.78 Mn
Dec 31, 2025 2.84 Mn
Sep 30, 2025 2.37 Mn
Jun 30, 2025 2.21 Mn
Mar 31, 2025 995,371.00
Dec 31, 2024 1.10 Mn
Sep 30, 2024 761,755.00
Jun 30, 2024 863,496.00
Mar 31, 2024 963,486.00
Dec 31, 2023 3.78 Mn
Sep 30, 2023 26.01 Mn
Jun 30, 2023 25.68 Mn
Mar 31, 2023 25.37 Mn
Dec 31, 2022 356.86 Mn
Sep 30, 2022 354.12 Mn
Jun 30, 2022 352.38 Mn
Mar 31, 2022 352.10 Mn
Dec 31, 2021 352.06 Mn